On Argentina footballer Lionel Messi’s event, Telangana BJP President N Ramchander Rao said, "Football icon Messi visited ...

At 83, Amitabh Bachchan shares that he kept working till 5.30 am in the morning: 'Just forgot there was…' US preparing for a ...

Construction of Fiji’s first-ever Super Speciality Hospital will officially begin in 2026. This new hospital will ensure ...

December 1, 2025 Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAP Biodexa ...

Discover how mothers in Gombe are using orange-fleshed sweet potatoes to fight child malnutrition. This local, vitamin-A rich ...

Fast Track designation supported by positive results from the KT-621 BroADen Phase 1b atopic dermatitis (AD) patient trial . KT-621 BROADEN2 Phase 2b AD trial ongoing, with data e ...

Company to host video conference call and webcast at 8:00 a.m. ET on Monday, December 8, 2025WATERTOWN, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) ...

The new AI Access Agent reflects Kontakt.io's ethos of delivering solutions that are fast, easy, scalable, and smart. By instantly unifying real-time RTLS signals with available data, it removes the ...

Given the strong pre-launch prescribing intentions, oral semaglutide is poised for swift market uptake upon FDA approval. Still, Novo Nordisk will need robust promotional efforts to counter currently ...

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...

Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant ...

New Peer-Reviewed Publication Highlights Phase 2 SPRING Trial Data Supporting the Disease Modifying Potential of Nebokitugin PSC and Supports Advancement to aPhase 3 Registration Trial- ...